IGHE and allergic disease: So far, it is unclear whether repeated administration and thus persistent blockade of IgE-mediated allergen presentation to T cells could possibly also result in a long-term loss of allergy-specific T helper 2 activity, for example through T cell deletion or anergy, as is has been shown for AIT [42, 44].